Karlijn Van Loon
Amsterdam, NH 1081HV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Protocol for recombinant expression in E. coli and purification of iBoost vaccine proteins using immobilized metal affinity chromatography.
Journal: STAR protocols
Published: January 09, 2026
Apelin in glioblastoma: A dual target for tumor and vascular intervention.
Journal: Vascular pharmacology
Published: July 07, 2025
Conjugate vaccine technology enhances responses to influenza virus.
Journal: Vaccine
Published: May 28, 2025
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 17, 2025
Guided design for the development of an evolution-proof influenza vaccine.
Journal: Vaccine
Published: November 20, 2024
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine.
Journal: Vaccine
Published: October 16, 2024
Extracellular vimentin as a versatile immune suppressive protein in cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 15, 2023
Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19.
Journal: iScience
Published: February 23, 2022
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.
Journal: Nature communications
Published: June 27, 2021
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis.
Journal: Cancer metastasis reviews
Published: September 09, 2020
FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.
Journal: Journal for immunotherapy of cancer
Published: July 20, 2020
Last Updated: 09/26/2026